Intermittent androgen-deprivation therapy in the management of castrate-resistant prostate cancer (CRPCa): Results of a multi-institutional randomized prospective clinical trial.
Michael Organ
No relevant relationships to disclose
Lori Wood
No relevant relationships to disclose
Derek Wilke
No relevant relationships to disclose
Chris Skedgel
No relevant relationships to disclose
Kara Thompson
No relevant relationships to disclose
Scott North
No relevant relationships to disclose
Tina Cheng
No relevant relationships to disclose
Susan Winch
No relevant relationships to disclose
Ricardo Rendon
No relevant relationships to disclose